{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:13:20Z","timestamp":1791483200788,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Innovative Medicine Initiative","award":["115632"],"award-info":[{"award-number":["115632"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s40264-018-0699-2","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T01:02:50Z","timestamp":1532394170000},"page":"1355-1369","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Assessment of the Utility of Social Media for Broad-Ranging Statistical Signal Detection in Pharmacovigilance: Results from the WEB-RADR Project"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-1716","authenticated-orcid":false,"given":"Ola","family":"Caster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Laure","family":"K\u00fcrzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4595-230X","authenticated-orcid":false,"given":"G. Niklas","family":"Nor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Tcherny-Lessenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Vroman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Wisniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"van Stekelenborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"699_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1109\/MIS.2010.151","volume":"25","author":"D Zeng","year":"2010","unstructured":"Zeng D, Chen H, Lusch R, Li SH. Social media analytics and intelligence. IEEE Intell Syst. 2010;25:13\u20136.","journal-title":"IEEE Intell Syst"},{"key":"699_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2165\/11590720-000000000-00000","volume":"34","author":"IR Edwards","year":"2011","unstructured":"Edwards IR, Lindquist M. Social media and networks in pharmacovigilance. Drug Saf. 2011;34:267\u201371.","journal-title":"Drug Saf"},{"key":"699_CR3","doi-asserted-by":"publisher","unstructured":"Yang CC, Yang H, Jiang L, Zhang M. Social media mining for drug safety signal detection. Proceedings of the 2012 international workshop on smart health and wellbeing (SHB \u201812), Maui, HI, United States, 29 Oct-2 Nov 2012, p. 33\u201340. \n                    https:\/\/doi.org\/10.1145\/2389707.2389714\n                    \n                  .","DOI":"10.1145\/2389707.2389714"},{"key":"699_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40264-015-0379-4","volume":"39","author":"A Sarker","year":"2016","unstructured":"Sarker A, O\u2019Connor K, Ginn R, Scotch M, Smith K, Malone D, et al. Social media mining for toxicovigilance: automatic monitoring of prescription medication abuse from Twitter. Drug Saf. 2016;39:231\u201340.","journal-title":"Drug Saf"},{"key":"699_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40264-016-0491-0","volume":"40","author":"CE Pierce","year":"2017","unstructured":"Pierce CE, Bouri K, Pamer C, Proestel S, Rodriguez HW, Van Le H, et al. Evaluation of Facebook and Twitter monitoring to detect safety signals for medical products: an analysis of recent FDA safety alerts. Drug Saf. 2017;40:317\u201331.","journal-title":"Drug Saf"},{"key":"699_CR6","first-page":"167","volume":"31","author":"M Bhattacharya","year":"2017","unstructured":"Bhattacharya M, Snyder S, Malin M, Truffa MM, Marinic S, Engelmann R, et al. Using social media data in routine pharmacovigilance: a pilot study to identify safety signals and patient perspectives. Pharmaceut Med. 2017;31:167\u201374.","journal-title":"Pharmaceut Med."},{"key":"699_CR7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s40264-014-0155-x","volume":"37","author":"CC Freifeld","year":"2014","unstructured":"Freifeld CC, Brownstein JS, Menone CM, Bao W, Filice R, Kass-Hout T, et al. Digital drug safety surveillance: monitoring pharmaceutical products in Twitter. Drug Saf. 2014;37:343\u201350.","journal-title":"Drug Saf"},{"key":"699_CR8","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/jamia\/ocw180","volume":"24","author":"A Cocos","year":"2017","unstructured":"Cocos A, Fiks AG, Masino AJ. Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts. J Am Med Inform Assoc. 2017;24:813\u201321.","journal-title":"J Am Med Inform Assoc"},{"key":"699_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s40264-015-0385-6","volume":"39","author":"GE Powell","year":"2016","unstructured":"Powell GE, Seifert HA, Reblin T, Burstein PJ, Blowers J, Menius JA, et al. Social media listening for routine post-marketing safety surveillance. Drug Saf. 2016;39:443\u201354.","journal-title":"Drug Saf"},{"key":"699_CR10","doi-asserted-by":"publisher","first-page":"140043","DOI":"10.1038\/sdata.2014.43","volume":"1","author":"R Harpaz","year":"2014","unstructured":"Harpaz R, Odgers D, Gaskin G, DuMouchel W, Winnenburg R, Bodenreider O, et al. A time-indexed reference standard of adverse drug reactions. Sci Data. 2014;1:140043.","journal-title":"Sci Data."},{"key":"699_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/009286150804200501","volume":"42","author":"M Lindquist","year":"2008","unstructured":"Lindquist M. VigiBase, the WHO global ICSR database system: basic facts. Drug Inform J. 2008;42:409\u201319.","journal-title":"Drug Inform J."},{"key":"699_CR12","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/pds.1742","volume":"18","author":"A Bate","year":"2009","unstructured":"Bate A, Evans SJW. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf. 2009;18:427\u201336.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"699_CR13","volume-title":"Practical aspects of signal detection in pharmacovigilance","author":"CIOMS Working Group XIII","year":"2010","unstructured":"CIOMS Working Group XIII. Practical aspects of signal detection in pharmacovigilance. Geneva: CIOMS; 2010."},{"key":"699_CR14","first-page":"465","volume":"304","author":"T Delamothe","year":"1992","unstructured":"Delamothe T. Reporting adverse drug reactions. BMJ. 1992;304:465.","journal-title":"BMJ."},{"key":"699_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJW Evans","year":"2001","unstructured":"Evans SJW, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10:483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"699_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s002280050466","volume":"54","author":"A Bate","year":"1998","unstructured":"Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, et al. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol. 1998;54:315\u201321.","journal-title":"Eur J Clin Pharmacol"},{"key":"699_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0962280211403604","volume":"22","author":"GN Nor\u00e9n","year":"2013","unstructured":"Nor\u00e9n GN, Hopstadius J, Bate A. Shrinkage observed-to-expected ratios for robust and transparent large-scale pattern discovery. Stat Methods Med Res. 2013;22:57\u201369.","journal-title":"Stat Methods Med Res"},{"key":"699_CR18","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40264-015-0289-5","volume":"38","author":"G Candore","year":"2015","unstructured":"Candore G, Juhlin K, Manlik K, Thakrar B, Quarcoo N, Seabroke S, et al. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug Saf. 2015;38:577\u201387.","journal-title":"Drug Saf"},{"key":"699_CR19","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s40264-014-0198-z","volume":"37","author":"GN Nor\u00e9n","year":"2014","unstructured":"Nor\u00e9n GN, Caster O, Juhlin K, Lindquist M. Zoo or savannah? Choice of training ground for evidence-based pharmacovigilance. Drug Saf. 2014;37:655\u20139.","journal-title":"Drug Saf"},{"key":"699_CR20","unstructured":"Leaman R, Wojtulewicz L, Sullivan R, Skariah A, Yang J, Gonzalez G. Towards internet-age pharmacovigilance: extracting adverse drug reactions from user posts to health-related social networks. Proceedings of the 2010 workshop on biomedical natural language processing (BioNLP \u201810), Uppsala, Sweden,\n15 July 2010, p. 117\u201325."},{"key":"699_CR21","doi-asserted-by":"publisher","unstructured":"Bian J, Topaloglu U, Yu F. Towards large-scale twitter mining for drug-related adverse events. Proceedings of the 2012 international workshop on smart health and wellbeing (SHB \u201812), Maui, HI, United States, 29 Oct\u20132 Nov 2012, p. 25\u201332. \n                    https:\/\/doi.org\/10.1145\/2389707.2389713\n                    \n                  .","DOI":"10.1145\/2389707.2389713"},{"key":"699_CR22","doi-asserted-by":"publisher","DOI":"10.2196\/10466","author":"ML K\u00fcrzinger","year":"2018","unstructured":"K\u00fcrzinger ML, Schuck S, Texier N, Adbellaoui R, Faviez C, Pouget J, et al. Web-based signal detection using medical forums data in France. J Med Internet Res. 2018. \n                    https:\/\/doi.org\/10.2196\/10466\n                    \n                  .","journal-title":"J Med Internet Res"},{"key":"699_CR23","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.2196\/publichealth.6174","volume":"3","author":"SL Anderson","year":"2017","unstructured":"Anderson SL, Bell GH, Gilbert M, Davidson EJ, Winter C, Barratt JM, et al. Using social listening data to monitor misuse and nonmedical use of Bbpropion: a content analysis. JMIR Public Health Surveill. 2017;3:e6.","journal-title":"JMIR Public Health Surveill."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-018-0699-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-018-0699-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T19:16:16Z","timestamp":1563909376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-018-0699-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["699"],"URL":"https:\/\/doi.org\/10.1007\/s40264-018-0699-2","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"24 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The research leading to these results was conducted as part of the WEB-RADR consortium (), which is a public\u2013private partnership coordinated by the Medicines and Healthcare products Regulatory Agency. The WEB-RADR project has received support from the Innovative Medicine Initiative Joint Undertaking () under Grant Agreement No. 115632, resources of which are composed of financial contributions from the European Union\u2019s Seventh Framework Programme (FP7\/2007-2013) and the European Federation of Pharmaceutical Industries and Associations companies\u2019 in-kind contribution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Magnus Lerch provided scientific advice and support to Bayer Pharma AG within the WEB-RADR project and has received compensation for his work from Bayer AG. Antoni Wisniewski is a full-time paid employee of AstraZeneca and holds shares in AstraZeneca. Ola Caster, Juergen Dietrich, Marie-Laure K\u00fcrzinger, Simon Maskell, G. Niklas Nor\u00e9n, St\u00e9phanie Tcherny-Lessenot, Benoit Vroman and John van Stekelenborg have no conflicts of interest that are directly relevant to the content of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}